C. Heymanslaan 10
- Work Place
09 332 06 98
Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1 : a Phase IIa randomised controlled study
(2019) Sofie Rutsaert (UGent), Jean-Marc Steens, Paul Gineste, Basiel Cole (UGent), Sam Kint (UGent), P Noel Barrett, Jamal Tazi, Didier Scherrer, Hartmut J Ehrlich, Linos Vandekerckhove (UGent)
Personal data from this phone book may only be used for communication with individuals in the context of the mission of Ghent University.